RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Cash from operations

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.3B
P/E ratio
SummaryFinancials
Period EndCash from operations (Million USD)YoY (%)
Dec 31, 2024-501+62.90%
Dec 31, 2023-308+12.08%
Dec 31, 2022-274-990.84%
Dec 31, 202131-14.19%
Dec 31, 202036-89.62%
Dec 31, 2019346-42.66%
Dec 31, 2018603+246.19%
Dec 31, 2017174-255.34%
Dec 31, 2016-112-630.67%
Dec 31, 201521+236.12%
Dec 31, 20146-90.10%
Dec 31, 201363+3284.49%
Dec 31, 20122-101.63%
Dec 31, 2011-115+80.52%
Dec 31, 2010-64

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)